✦ LIBER ✦

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

✍ Scribed by F.Y.F.L. De Vos; H.W.M. van Laarhoven; J.S.E. Laven; A.P.N. Themmen; L.V.A.M. Beex; C.G.J. Sweep; C. Seynaeve; A. Jager

Book ID: 119222914
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 333 KB
Volume: 84
Category: Article
ISSN: 1040-8428
DOI: 10.1016/j.critrevonc.2012.06.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormonal therapy in Post menopausal rece

Hormonal therapy in Post menopausal receptor positive Breast cancer patients-practices and perceptions

✍ Bheem Sangars; S. Varadarajan; T. Suriyakumaran 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Adherence to adjuvant therapy in post-me

Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review

✍ M. BANNING 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

Direct comparisons of adjuvant endocrine

Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status

✍ Yasuo Nomura; Mitsunori Shirouzu; Takahiro Takayama 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 701 KB

Adjuvant Chemotherapy and Hormonal Thera

Adjuvant Chemotherapy and Hormonal Therapy for Older Adults With Breast Cancer

✍ Arti Hurria 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Menopausal hormone replacement therapy a

Menopausal hormone replacement therapy and breast cancer: A meta-analysis

✍ M Sillero-Arenas; M Delgado-Rodriquez; R Rodigues-Canteras; A Bueno-Cavanillas; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Current and future status of adjuvant th

Current and future status of adjuvant therapy for breast cancer

✍ Robert E. Coleman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Adjuvant systemic treatments have greatly improved the prognosis of women with early breast cancer. Combination chemotherapy and, for patients with oestrogen receptor-positive (ER+) tumours, endocrine treatment has been found to reduce the frequency of relapse and improve survival. New adjuvant stra